Release Date: 03/10/17 16:14 Summary: Notice of annual general meeting Price Sensitive: Yes Download Document 486.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%